↓ Skip to main content

Dove Medical Press

Is Tofacitinib Effectiveness in Patients with Rheumatoid Arthritis Better After Conventional Than After Biological Therapy? – A Cohort Study in a Colombian Population

Overview of attention for article published in Biologics: Targets & Therapy, July 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user

Readers on

mendeley
6 Mendeley
Title
Is Tofacitinib Effectiveness in Patients with Rheumatoid Arthritis Better After Conventional Than After Biological Therapy? – A Cohort Study in a Colombian Population
Published in
Biologics: Targets & Therapy, July 2022
DOI 10.2147/btt.s361164
Pubmed ID
Authors

Pedro Santos-Moreno, Susan Martinez, Linda Ibata, Laura Villarreal, Fernando Rodríguez-Florido, Manuel Rivero, Adriana Rojas-Villarraga, Claudio Galarza-Maldonado

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 6 100%

Demographic breakdown

Readers by professional status Count As %
Professor > Associate Professor 1 17%
Researcher 1 17%
Student > Doctoral Student 1 17%
Unknown 3 50%
Readers by discipline Count As %
Medicine and Dentistry 4 67%
Unknown 2 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 July 2022.
All research outputs
#20,673,680
of 25,392,582 outputs
Outputs from Biologics: Targets & Therapy
#224
of 284 outputs
Outputs of similar age
#328,244
of 439,890 outputs
Outputs of similar age from Biologics: Targets & Therapy
#3
of 5 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 284 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one is in the 14th percentile – i.e., 14% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 439,890 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.